공지사항

Pancreatic Cancer Lawsuit Settlements

Pancreatic cancer is an aggressive disease that is difficult to identify in its initial stages. The prognosis for pancreatic cancer is based on the stage, if the cancer can be surgically removed and the other options available to treat it.

If you or someone you know developed pancreatic cancer kidney damage, pancreatic cancer or another serious illness after taking Prilosec or Nexium You may be eligible to file a PPI lawsuit. Learn more about how to file claims.

Januvia and Janumet Lawsuits

The Januvia pancreatic cancer lawsuits allege that Merck put profit ahead of the safety of consumers when it came to marketing the diabetes drug. Januvia the most popular drug sold by Merck, has brought in more than $5 billion in sales.

Numerous academic studies and post-marketing studies suggest that incretin mimics Januvia (sitagliptin) can cause pancreatic cancer. This is of great worry, since Pancreatic cancer lawsuit carcinoma is usually in an advanced stage at the time of diagnosis, and there aren't many effective treatments available.

The lawsuits brought by the families of patients who died from pancreatic cancer have included Merck, Amylin Pharmaceuticals, Eli Lilly and Bristol-Myers Squibb as defendants. The lawsuits assert that the companies knew or should have knew that their Type 2 diabetes medications could cause pancreatic cancer, but did not adequately warn patients and doctors about the dangers.

In 2016, the court consolidated Januvia, Byetta, and Janumet lawsuits into an inter-district litigation proceeding under Judge Anthony Battaglia. In 2017, the plaintiffs achieved an important victory when the 9th Circuit Court of Appeals overturned a lower court decision that had ruled against and reinstated these cases.

The people who took Januvia and were diagnosed with Pancreatic cancer railroad lawsuits cancer may be entitled to compensation for medical expenses, Pancreatic cancer lawsuit settlements lost earnings, funeral expenses or pre-death suffering and pain damages and other losses. The lawyers at National Injury Help are reviewing possible claims and offering an initial consultation at no cost to those who might be eligible to start a lawsuit.

Zantac Lawsuits

Zantac lawsuits began filing shortly after the FDA recalled the heartburn medication's over-the-counter version in 2022 due to the discovery of cancer-causing N-nitrosodimethylamine (NDMA) contamination. Following the discovery of the contamination, more than 50,000 claims were submitted to federal courts. The cases were consolidated by U.S. District Court Judge Robin Rosenberg of Florida into a multi-district court. Plaintiffs claimed that Zantac's producers knew about the dangers that ranitidine could pose but did not warn consumers. The lawsuits claim that the companies were aware or ought to have been aware that the over-the-counter medicine was contaminated with NDMA and can cause esophageal, bladder, and liver cancers, as well as pancreatic cancers. Other claims assert that the over-the-counter medication also caused other adverse effects, such as ulcers and diarrhea.

The trial was set to begin in California this summer, and other trials in the MDL were slated to start following that. However the MDL judge dismissed the case in December 2022 after he decided that plaintiffs' expert evidence was not reliable. The judge claimed that the evidence from science was speculative and unconclusive to justify the claims.

The ruling is a devastating loss to the hopes of plaintiffs for justice and fair compensation. But, there is hopes that the upcoming bellwether trials will give us an insight into the types of verdicts by juries that could be handed down in these cases. If the trials go well they could help defendants to settle their claims quicker.

Camp Lejeune Lawsuits

The Camp Lejeune Marine Corps Base's drinking water was contaminated by volatile organic compounds. The water contamination caused serious health issues to the people who lived or worked at the Marine base. The illnesses that were affected included cancers including kidney cancer, bladder cancer, multiple myeloma, Non-Hodgkin's lymphoma, and more. Our law firm can assist you when you or a member of your family suffered injuries as a result of the contaminated water that was found in Camp Lejeune. Our experienced personal injury as well as product liability and mass tort attorneys have more than 130 years of combined experience. Our clients have secured more than $250 million.

Anyone who was employed at Camp Lejeune 30 days or longer during the contamination period is able to file a compensation claim. Anyone who has a deceased family member who died from an illness believed to be connected to the contaminated drinking water at Camp Lejeune can also file an action for wrongful death.

The value of a victim's claim is determined by the severity of the injury and the effect it has had on their quality of living. For example the case of kidney cancer is likely to have a higher settlement value than a bladder cancer case. Bladder cancer cases, however, have stronger evidence that links them to the polluted water at Camp Lejeune.

The Camp Lejeune lawsuits were consolidated into a multidistrict litigation (MDL) in the Eastern District of North Carolina federal court. The MDL will create a single master complaint for all lawsuits. It will also set up processes to consolidate discovery motions related to coordinate experts and motions dispositive of coordinates.

Ranitidine Lawsuits

Millions of people across America use Zantac (and generic ranitidine) to treat ulcers, acid reflux and other stomach problems. It was among the top-selling medicines of all time until tests revealed that it may contain a cancer-causing chemical known as NDMA.

Since the discovery of NDMA in ranitidine, thousands of lawsuits have been filed against companies which manufacture and sell this popular medicine. These lawsuits were put together into an federal multidistrict case that is managed by U.S. District judge Robin Rosenberg in the Southern District of Florida. In addition to the MDL several lawsuits have been filed in state court.

These lawsuits assert that the makers of ranitidine were aware NDMA however they failed to warn their users of its danger. If they succeed, plaintiffs may be awarded compensation for their harms.

The defendants will likely try and keep some of these claims from the courts by claiming that the evidence doesn't meet certain legal standards. Particularly they will claim that there isn't sufficient evidence to show that NDMA in Zantac causes certain types of cancer. They may also claim preexisting conditions such as stomach polyps or obesity are responsible for the cancer of the plaintiff and not the NDMA found in Zantac. If the plaintiff proves that the cancer was caused the NDMA found in Zantac they may be able obtain damages.